Concepedia

Katherina Sewald

KS

Statistics

Publications

59

Citations

2.7K

H-Index

33

Active since

2004

Affiliations

Fraunhofer Institute for Toxicology and Experimental Medicine(Current)

German Center for Lung Research

Medizinische Hochschule Hannover

Klinikum Region Hannover

RWTH Aachen University

Katherina Sewald is an author at Fraunhofer Institute for Toxicology and Experimental Medicine specializing in immunology, life sciences, and pharmacy.

ORCID

Publications per year

2004–2024

59

Publications

59

A toxicological evaluation of inhaled solid lipid nanoparticles used as a potential drug delivery system for the lung

Matthias Nassimi, Carsten Schleh, HD Lauenstein et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2010 · 175 citations

, , +16

Bioreactor-based mass production of human iPSC-derived macrophages enables immunotherapies against bacterial airway infections

Mania Ackermann, Henning Kempf, Miriam Hetzel et al. · Nature Communications · 2018 · 164 citations · Full text

, , +15

The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue

Melissa Zimniak, Luisa Kirschner, Helen Hilpert et al. · Scientific Reports · 2021 · 137 citations · Full text

, , +17

Ex vivo testing of immune responses in precision-cut lung slices

Maja Henjakovic, Katherina Sewald, Simone Switalla et al. · Toxicology and Applied Pharmacology · 2008 · 115 citations

, , +9

Low cytotoxicity of solid lipid nanoparticles in<i>in vitro</i>and<i>ex vivo</i>lung models

Matthias Nassimi, Carsten Schleh, Hans-Dieter Lauenstein et al. · Inhalation Toxicology · 2009 · 95 citations

, , +17

1–5 of 59